Brenda Coutinho, MD
Obstetrics & Gynecology · Milford, MANPI 1356303754
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,550 of the $2,014 with a category attached, or 77.0%. Medtronic accounts for 78.5% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $1,601 and has fallen 94.0% since, to $97 in 2025.
Across 18 payments — averaging $111.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Astellas Pharma US Inc$179
- Sage Therapeutics, LLC$67
- Myovant Sciences Inc.$48
- Mayne Pharma Commercial LLC$30
- BD$24
- plus $86 from 5 others
What the payments were for
- Consulting fees$1,55077%
- Travel & lodging$301%
- Food & beverage$33917%
- Education$945%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 3 | $1,580 |
| Astellas Pharma US Inc | 3 | $179 |
| Sage Therapeutics, LLC | 3 | $67 |
| Myovant Sciences Inc. | 2 | $48 |
| Mayne Pharma Commercial LLC | 1 | $30 |
| BD | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| AbbVie | 1 | $18 |
| Pfizer | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $14 |
| Sumitomo Pharma America, Inc. | 1 | $13 |
How this compares
$2,014 in reported general payments places this provider in the 85th percentile of 910 obstetrics & gynecology providers in Massachusetts.
See all obstetrics & gynecology providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol (Twice Weekly)Estradiol | 16 | $2,170 |
| Estradiol | 33 | $2,008 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Milford
- Brian BondMilford$6K
- Soheil Amin HanjaniBrockton$386K
- Joelle LiemanBrighton$215K
- Elizabeth OnyemelukweBoston$135K
- James GreenbergBoston$119K
- Stephanie AlimenaBoston$75K
- Denis VaughanBoston$38K
- Lara KingstonPlymouth$37K
- Erica RobinsonWorcester$32K
- Roxanne GardnerBoston$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.